Ligand validation:2ZIZ

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 2ZIZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2ZIZ_NAD_C_550	88%	28%	0.098	0.972	1.41	1.47	6	6	2	0	100%	1
2ZIZ_NAD_A_550	84%	20%	0.102	0.963	1.43	1.93	5	12	2	0	100%	1
2ZIZ_NAD_D_550	83%	23%	0.107	0.965	1.33	1.84	3	11	2	0	100%	1
2ZIZ_NAD_B_550	79%	16%	0.11	0.957	1.52	2.14	8	14	2	0	100%	1
3CE6_NAD_A_550	92%	30%	0.071	0.961	1.19	1.58	3	8	1	0	100%	1
2ZJ1_NAD_B_550	87%	21%	0.093	0.966	1.56	1.77	6	11	0	0	100%	1
2ZJ0_NAD_D_550	86%	23%	0.109	0.978	1.66	1.52	7	10	3	0	100%	1
3CMC_NAD_O_407	100%	18%	0.022	0.996	1.63	1.92	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.